首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.
【2h】

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.

机译:百日咳博德特氏菌和副百日咳博德特氏菌对七种氟喹诺酮类药物的体外敏感性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The in vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones were assessed by the agar dilution method. Ciprofloxacin and temafloxacin were the most active compounds (MIC for 90% of isolates tested [MIC90], 0.06 microgram/ml), while enoxacin and pefloxacin were the least active (MIC90, 0.5 microgram/ml). Fleroxacin, lomefloxacin, and ofloxacin showed intermediate activities (MIC90s, 0.125 to 0.25 microgram/ml). These results suggest a possible role for the fluoroquinolones in the treatment of pertussis, at least in adult patients.
机译:通过琼脂稀释法评估百日咳博德氏杆菌和副百日咳博德氏杆菌对七个氟喹诺酮类药物的体外敏感性。环丙沙星和特马沙星是活性最高的化合物(测试的90%分离株的MIC为[MIC90],0.06微克/毫升),而依诺沙星和培氟沙星的活性最低(MIC90,0.5微克/毫升)。氟罗沙星,洛美沙星和氧氟沙星显示出中等活性(MIC90,0.125至0.25微克/毫升)。这些结果表明氟喹诺酮类药物至少在成年患者中在百日咳治疗中可能发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号